CJA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Résumé de cet Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a scholarly reply
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Weinbroum, A. A.
Right arrow Articles by Geller, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weinbroum, A. A.
Right arrow Articles by Geller, E.
Canadian Journal of Anesthesia 48:963-972 (2001)
© Canadian Anesthesiologists' Society, 2001
General Anesthesia

Flumazenil improves cognitive and neuromotor emergence and attenuates shivering after halothane-, enflurane- and isoflurane-based anesthesia

[Le flumazénil améliore le retour de l'activité cognitive et neuromotrice et atténue les frissons après une anesthésie à base d'halothane, d'enflurane ou d'isoflurane]

Avi A. Weinbroum, MD and Eran Geller, MD

From the Post-Anesthesia Care Unit The Department Of Anesthesiology Critical Care Tel Aviv Sourasky Medical Center, The Sackler Faculty Of Medicine Tel Aviv University Tel Aviv Israel.

Dr. Avi A. Weinbroum, Director, Post-Anesthesia Care Unit, Tel Aviv Sourasky Medical Center, 6 Weizman St. Tel-Aviv 64239, Israel. Phone: +972-3-6973237; Fax: +972-3-6925749; E-mail: draviw{at}tasmc.health.gov.il

Purpose: To conduct a randomized, placebo-controlled, double-blinded, clinical experiment testing the hypothesis that flumazenil, a benzodiazepine antagonist, may affect recovery from halothane-, enflurane- and isoflurane-based anesthesia.

Method: Patients who underwent surgery under N2O/O2 plus halothane (n=100), enflurane (n=100) or isoflurane (n=70) anesthesia were administered flumazenil 1 mg or placebo upon emergence from anesthesia, and their postanesthesia vital signs, vigilance, neurological recovery, shivering, amnesia reversal, and general subjective feeling were assessed.

Results: A ten-point vigilance score showed better recovery of flumazenil-treated patients compared to those who received placebo (60-min after halothane anesthesia: 9.9 ± 0.1 vs 9.5 ± 0.2, P <0.01; after enflurane: 10 ± 0 vs 9.4 ± 0.2, P <0.01; after isoflurane: 10.0 ± 0 vs 9.3 ± 0.1, P <0.01). Halothane- and enflurane-flumazenil-treated patients (but not isoflurane) reached a better neurological score (2.97 ± 0.05 or 3 ± 0) compared to placebo (2.8 ± 0.4 or 2.6 ± 0.4, P <0.01), respectively. Reversal of amnesia was superior in the flumazenil group at 60 min and at 24 hr postsurgery, and more flumazenil patients rated recovery as "pleasant". Flumazenil patients shivered less than placebo patients despite their lower core temperature (at 30 min: halothane: 11% vs 28%, P <0.05; enflurane: 11% vs 30%, P <0.05; isoflurane: 17% for both groups).

Conclusion: Flumazenil improves recovery of high cortical and neuromotor functions following halothane, enflurane and isoflurane anesthesia, reduces shivering and improves the overall quality of emergence, including patients' subjective feeling.




This article has been cited by other articles:


Home page
 Anesth. Analg.Home page
P. Kranke, L. H. Eberhart, N. Roewer, and M. R. Tramer
Single-Dose Parenteral Pharmacological Interventions for the Prevention of Postoperative Shivering: A Quantitative Systematic Review of Randomized Controlled Trials
Anesth. Analg., September 1, 2004; 99(3): 718 - 727.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the Canadian Anesthesiologists' Society.